AcuPartD

Keeping you updated on the latest Medicare and Part D news

FDA’s Mini-Sentinel Project Monitors Drug Complications

Leave a comment

The FDA is using a “big data” approach to monitoring the safety of marketed drugs. The Mini-Sentinel, which took 5 years to create, can look through the billing records of nearly 180 million Americans to find connections between drugs and health complications. The program now runs hundreds of queries a year.

Article

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s